This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poljak, M.
Right arrow Articles by Marin, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Poljak, M.
Right arrow Articles by Marin, I. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, March 1999, p. 796-797, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Comparative Evaluation of First- and Second-Generation Digene Hybrid Capture Assays for Detection of Human Papillomaviruses Associated with High or Intermediate Risk for Cervical Cancer

Mario Poljak,1,* Anja Brencic,1 Katja Seme,1 Adriana Vince,2 and Irena J. Marin1

Institute of Microbiology and Immunology, Medical Faculty, Ljubljana, Slovenia,1 and Dr. Fran Mihaljevic' University Hospital for Infectious Diseases, Zagreb, Croatia2

Received 2 July 1998/Returned for modification 22 October 1998/Accepted 17 November 1998

In the present study we comparatively evaluated the first- and second-generation Digene Hybrid Capture assays for detection of human papillomaviruses (HPV) associated with high or intermediate risk for cervical cancer in cervical specimens. Concordant results were obtained with 468 of 483 (96.8%) specimens. All 15 specimens which gave repeatedly discordant results were positive by the second-generation test only, and 14 of them tested PCR positive. The enhanced sensitivity of the second-generation assay is mainly a result of the reformulation of hybridization reagents and, to a lesser extent, a result of the addition of new HPV probes.

* Corresponding author. Mailing address: Institute of Microbiology and Immunology, Medical Faculty, Zaloska 4, 1105 Ljubljana, Slovenia. Phone: 386 61 1403 042. Fax: 386 61 1423 518. E-mail: poljak{at}animus.mf.uni-lj.si.

Journal of Clinical Microbiology, March 1999, p. 796-797, Vol. 37, No. 3
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Poljak, M., Kocjan, B. J., Kovanda, A., Lunar, M. M., Lepej, S. Z., Planinic, A., Seme, K., Vince, A. (2009). Human Papillomavirus Genotype Specificity of Hybrid Capture 2 Low-Risk Probe Cocktail. J. Clin. Microbiol. 47: 2611-2615 [Abstract] [Full Text]  
  • Stevens, M. P., Garland, S. M., Rudland, E., Tan, J., Quinn, M. A., Tabrizi, S. N. (2007). Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results. J. Clin. Microbiol. 45: 2130-2137 [Abstract] [Full Text]  
  • Stevens, M. P., Rudland, E., Garland, S. M., Tabrizi, S. N. (2006). Assessment of MagNA Pure LC Extraction System for Detection of Human Papillomavirus (HPV) DNA in PreservCyt Samples by the Roche AMPLICOR and LINEAR ARRAY HPV Tests.. J. Clin. Microbiol. 44: 2428-2433 [Abstract] [Full Text]  
  • Soderlund-Strand, A., Rymark, P., Andersson, P., Dillner, J., Dillner, L. (2005). Comparison between the Hybrid Capture II Test and a PCR-Based Human Papillomavirus Detection Method for Diagnosis and Posttreatment Follow-Up of Cervical Intraepithelial Neoplasia. J. Clin. Microbiol. 43: 3260-3266 [Abstract] [Full Text]  
  • Coste, J., Cochand-Priollet, B., de Cremoux, P., Le Gales, C., Cartier, I., Molinie, V., Labbe, S., Vacher-Lavenu, M.-C., Vielh, P. (2003). Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ 326: 733-733 [Abstract] [Full Text]  
  • Moselhi, M., Wright, Jr, T. C., Kuhn, L., Denny, L. (2000). Human Papillomavirus Detection to Screen for Cervical Cancer. JAMA 284: 39-40 [Full Text]  
  • Cox, J. T. (1999). Evaluating the Role of HPV Testing for Women With Equivocal Papanicolaou Test Findings. JAMA 281: 1645-1647 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»